English key-point edition · Content updated 2026-10-12
This guide summarizes the main points of our Chinese article. Confirm your personal test preparation and treatment instructions with the clinical team.
Three different roles
NIPT analyzes cell-free DNA in maternal blood as a screening test. Amniocentesis collects amniotic fluid under ultrasound guidance for the chromosome or genetic tests selected in advance. Ultrasound assesses fetal structures and growth; it does not replace chromosome diagnosis.
When to discuss testing
Start the conversation early in pregnancy, considering gestational age, the number of babies, family history and ultrasound findings. Amniocentesis is commonly considered at 15–20 weeks, although later testing may be appropriate. The suitable timing and scope of NIPT vary by test.
Understanding an NIPT result
A high-risk result calls for counseling and discussion of diagnostic confirmation, not an irreversible decision based on screening alone. Low risk does not exclude every condition or every missed case. An inconclusive result is not a normal result: discuss its implications and whether to repeat the blood test or consider diagnostic testing.
Before amniocentesis
Ask the performing team about miscarriage, infection and fluid leakage risks in your situation. The sampling procedure and the laboratory analysis—such as a karyotype or chromosome microarray—are separate choices. Discuss test limitations, uncertain findings, turnaround time and fees.
After testing
No test can exclude every disease, and routine prenatal follow-up remains important. After amniocentesis, contact the team immediately for significant pain, bleeding, fluid leakage or fever.
Sources
This guide provides general information. Your symptoms, test results and treatment plan require individual clinical assessment.
Back to all guides